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Abstract
Visceral leishmaniasis (VL) is a zoonotic parasitic disease caused by Leishmania 
infantum (L. chagasi) that infects cells of the monocyte-phagocyte system. This work 
aims to describe the bone marrow parasitism in dogs naturally infected by L. chagasi, 
and to correlate with serum concentrations of cytokines and antibody level. It evalu-
ated 42 dogs, 21 uninfected and 21 infected by L. infantum, of both sexes and of dif-
ferent ages; dogs were classified into three clinical stages: stage I, mild disease; stage 
II, moderate disease; and stage III, severe disease. Parasitic index was determined by 
real-time polymerase chain reaction (PCR) and cytokine serum concentration by 
flow cytometry. The average parasitic index of infected dogs was 4.59 × 1010 copies/
μl. IL-4 and TNF-α concentrations were higher in infected dogs than in the control 
group. Antibody levels were positively correlated with IL-4 expression. There was a 
significant positive correlation of IL-6 cytokine levels with the evolution of stages I 
and III. Antibody levels were positively correlated with IL-4 expression. There was a 
significant positive correlation of IL-6 cytokine levels with the evolution of stages I 
and III. However, this cytokine can be used as a marker to distinguish between differ-
ent clinical stages.
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1. Introduction
Visceral leishmaniasis (VL) is a parasitic zoonotic disease caused by the 
protozoan Leishmania infantum (syn. L. chagasi), an intracellular parasite of the 
phagocytic mononuclear system [1, 2]. In Brazil, VL is transmitted by sandflies, 
Lutzomyia longipalpis [1, 3, 4].
In a global scenario, it is estimated that 300,000 new cases of VL occur with a 
rate of 20,000 deaths each year, with 94% new cases reported in Brazil, Ethiopia, 
India, Kenya, Somalia, South Sudan, and Sudan [5]. While in Latin America, LV 
spreads from Mexico to Argentina, with the largest number of cases concentrated 
in Brazil [6]. With the urbanization of VL in Brazil, annually, the country records 
approximately 3500 new cases, mainly in medium and large cities; probably, it is 
due to the disordered anthropic occupation of the geographic space [7].  
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Despite scientific advances, cases of VL are expanding, which has a major impact on 
public health, as dogs are the main reservoirs in the urban environment and there-
fore play an important role in the transmission cycle [8, 9].
Canine visceral leishmaniasis (CVL) is characterized by a broad clinical spec-
trum, from mild and moderate to fatal clinical manifestations. Major clinical signs 
in dogs include hepatosplenomegaly, lymphadenopathy, exfoliative dermatitis, 
alopecia, onychogryphosis, keratoconjunctivitis, apathy, anorexia, and severe 
weight loss [10–13].
The clinical manifestation of CVL depends on the interaction of the parasite 
with the host immune response [2]. In susceptible dogs, clinicopathological abnor-
malities are preceded by an evident humoral response and depression of the cellular 
response, mediated by a non-protective Th2 immune response associated with 
cytokines IL-4, IL-5, IL-6, and IL-10 [14, 15]. Dogs that do not develop the disease 
have a protective cellular response (Th1) [16, 17], related to INF-γ, TNF-α, IL-2, 
and IL-12 cytokines.
Different procedures are used for the diagnosis of CVL [18]. The Brazilian 
Ministry of Health recommends serology in the investigation of canine disease by 
the Dual-Path Platform (DPP®) rapid method as a screening test and ELISA as 
confirmatory test [19]. Other tests are used to demonstrate infection, such as cytol-
ogy, histopathology [20], and real-time PCR (RT-PCR) [21].
Similarly, determination of parasitic index has become important for early 
detection, but also evaluation of treatment efficacy and monitoring of relapses 
[22]. Thus, the aim of this study was to associate parasitic index to serum cytokine 
concentration in dogs naturally infected by L. infantum at different clinical stages of 
infection.
2. Methodological aspects
The procedures were previously approved by the Ethics Committee on the Use of 
Animals (ECUA)/UFMT, Brazil (n° 23108.019567/14-1), and collection of clinical 
samples was authorized by the dog owners by signing the informed consent form.
2.1 Animals
This study was conducted over a 16-month period, evaluating 42 male and 
female dogs of different ages and breeds from Barra do Garças, Mato Grosso State, 
Brazil (latitude, −15.893; longitude, 52.2599; south,15° 53′ 35″; west 52° 15′ 36″). 
Dogs with canine visceral leishmaniasis (n = 21) were classified into clinical stages 
at diagnosis as described by Solano et al. [23] and confirmed using the Dual-Path 
Platform Rapid Test (RT DPP®) and polymerase chain reaction (PCR). A control 
group (n = 21) was also formed, comprising dogs with no clinical changes and nega-
tive results for RT DPP® and conventional PCR.
2.2 Blood and bone marrow sample
Blood samples (5 mL) were collected by cephalic or jugular venipuncture, placed 
in tubes without anticoagulant to obtain serum. Serum was obtained by centrifug-
ing the blood sample at 300× g for 5 minutes and was then transferred to 2 mL 
microtubes and stored at −80°C for cytokine dosing.
After dog restraint and local anesthesia with 2% lidocaine, bone marrow samples 
were obtained from the sternal manubrium, placed in microtubes with 0.5 mL 0.9% 
sterile NaCl solution, and stored at −20°C for subsequent molecular techniques.
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2.3 Immunochromatographic rapid test: RT DPP® kit
The immunochromatographic rapid test for detection of anti-Leishmania 
infantum antibodies (DPP®—Canine Visceral Leishmaniasis-Bio-Manguinhos/
FIOCRUZ, Rio de Janeiro, Brazil) that uses the recombinant protein K39 (rK39) 
as an antigen, a cloned 39 amino acid sequence of the specific L. infantum kinase 
region, was performed according to the manufacturer’s guidance.
2.4 DNA extraction, conventional PCR, and qPCR
DNA extraction from blood samples was performed by the phenol-chloroform 
method. The polymerase chain reaction assay was performed using the primers 
RV1 (sense) 5′-CTT TTC TGG TCC CGC GGG TAG G-3′ and RV2 (antisense) 
5′-CCA CCT GGC TAT TTT ACA CCA-3′ [24], which amplifies the DNA frag-
ment of a 145 bp region of conserved kDNA present in L. infantum. Amplification 
used 200 mM dNTP, 1 pM from each primer, a buffer solution (10 mM Tris–HCl 
and 50 mM KCl, pH 8.3), 2 mM MgCl2, 1.5 U Taq DNA polymerase, and 2 μl 
of the DNA sample in the final volume of 25 μl. Assays were performed for one 
cycle at 94°C for 4 minutes, followed by 30 cycles at 94°C for 30 seconds, 60°C 
for 30 seconds, and 72°C for 30 seconds, and final extension of one cycle at 72°C 
for 10 minutes. The amplification product was fractionated by 2.0% agarose gel 
electrophoresis, stained with red gel spot, and visualized on a transilluminator 
(UV, 300 nm).
Quantitative PCR (qPCR) was performed in triplicate using the StepOne™ 
Real-Time PCR System Sequence Detection System (Applied Biosystems) targeting 
RV1–5′-CTT TTC TGG TCC GGG TAG G-3′ primers and RV2–5′-CCA CCT GGC 
TAT TTT ACA CCA-3′ amplifying a 145 bp sequence of L. infantum-specific kDNA 
[24]. Reactions were prepared in a 25 μl final volume containing SYBR Green Master 
Mix, 0.3 μM of each primer, and 2 μl of target DNA. Amplification conditions 
included an initial incubation step at 94°C for 10 minutes, followed by 40 cycles of 
amplification, 94°C for 15 seconds, and 60°C for 60 seconds. The standard curve 
was established for each assay using known amounts of TOPO PCR 2.1 plasmid 
(Invitrogen Corp.) containing L. infantum kDNA gene. Serial (10×) dilutions of 
the recombinant plasmid containing 2.9×104–2.9×108 copies of the plasmid were 
performed and used on the standard curve.
2.5 Cytokine quantification by flow cytometry
Serum cytokine concentration (IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, and 
IL-17) was assessed using the Cytometric Bead Array (CBA) Kit (BD Bioscience, 
USA) and evaluated by a flow cytometer (FACSCalibur®, BD Bioscience, USA). 
The reading was done using the CellQuest. Data were analyzed in FCAP array 
software version 5.0.
2.6 Determination of serum immunoglobulins
Immunoglobulin concentrations (IgM and IgG) in the sera were determined by 
turbidimetric method. For 1:11 (v/v) IgM and 1:15 (v/v) IgG, antibody concentra-
tions were determined using IgM (Bioclin®, Brazil, Ref K063) and IgG (Bioclin®, 
Brazil, Ref K062) antiserum diluted with 1:12 (v/v). The calibration curve obtained 
from the Multical calibrator (Bioclin®, Brazil, Ref K064) was used to determine 
the standard curve for each immunoglobulin. Positive and negative serum samples, 
standards, and controls were placed in 500 μl buffer solution (0.15 mol/L sodium 
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chloride, Tris 50 mmol/L, 6.0000 PEG 50 g/L, and sodium azide 15.38 nmol/L). The 
suspensions were mixed and incubated at 37°C for 10 minutes. Reactions were read 
on a spectrophotometer at 340 nm.
2.7 Statistical analysis
For the analysis of the concentration of cytokines and immunoglobulins (IgG 
and IgM), the Student t-test independent samples were used. For the quantification 
of parasitic index of the bone marrow and cytokines when compared by clini-
cal stage, Kruskal-Wallis analysis of variance was used. Parasite load correlation 
analysis of IgG in the presence of cytokines was also performed by calculating the 
Spearman correlation coefficient. Data were expressed as mean ± standard error. 
Values less than 0.05 (p < 0.05) were considered significant.
3. Results
Most of the 21 dogs in the control group were mongrel dog (15/71%), Labrador 
retriever (1/5%), dachshund (1/5%), pinscher (3/14%), and rottweiler (1/5%). Age 
ranged from 14 months to 8 years (average 3.4 years). Thirteen dogs were female 
(13/62%) and eight dogs were male (8/38%). Most of the 21 dogs with leishmaniasis 
were dogs from mongrel dog (12/57%), Labrador retriever (1/05%), American pit 
bull (1/05%), poodle (1/05%), and shih tzu (6/28%). Age ranged from 12 months 
to 11 years (mean 4.3 years). Six dogs were female (6/29%) and 15 dogs were male 
(15/72%).
At the time of clinical evaluation, all dogs diagnosed with VL had several 
clinicopathological findings typical of the disease. Clinical symptoms in seroposi-
tive animals (CVL) included lymphadenopathy (17/13%), skin ulcers (12/10%), 
onychogryphosis (11/09%), ear ulceration (11/09%), scaling (10/08%), weight 
loss (9/07%), dermatopathy (8/06%), ophthalmopathy (8/06%), muscle atrophy 
(4/03%), splenomegaly (7/06%), alopecia (6/05%), lethargy (5/04%), periocular 
alopecia (4/03%), skin nodules (3/02%), hepatomegaly (3/02%), cachexia (3/02%), 
and hyperkeratosis (2/01%).
Dogs were classified into three clinical stages: stage I, mild disease (n = 5/24%); 
stage II, moderate disease (n = 9/43%); and stage III, severe disease (n = 7/33%). 
Stage II dogs were not subclassified.
Leishmania infantum DNA was detected in all dogs of the group with CVL up to a 
concentration of 1 fg/μl. Real-time PCR of bone marrow samples was positive in all 
dogs in the CVL group (100%). There was no statistical difference in the distribu-
tion between clinical stages and parasitic index, as shown in Table 1.
The mean and standard error of concentrations (pg/ml) of IL-2, IL-4, IL-6, 
IL-10, TNF-α, IFN-γ, and IL-17 cytokines based on clinical staging in CVL-infected 
dogs are shown in Table 1. It was observed that IL-6 and TNF-α concentrations 
increased in serum of infected dogs with significant statistical difference between 
the clinical stages of CVL, although most infected dogs had moderate and severe 
clinical manifestations of the disease.
Among dogs with CVL and uninfected dogs, an increase of IL-4 and TNF-α 
concentrations in serum from dogs infected with CVL was observed. Similar serum 
concentrations of IL-2, IL-10, IL-17, and IFN-γ were observed between the groups 
studied (Table 2).
When comparing immunoglobulin means, IgG levels were elevated in the 
CVL group when compared to IgM levels. A significant difference (p = <0.0001) 
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was observed. Similarly, IgG concentration between the control and CVL 
groups was evaluated. IgG levels were found to be higher in serum from dogs 
with CVL (2300.75 ± 678.463) when compared to control group IgG concentra-
tions (636.94 ± 312.8 mg/dl), showing a significant difference between groups 
(p = <0.0001). Regarding the comparison of IgM concentration (mg/dl) in the CVL 
group (279.74 ± 37.755) compared to the control group (241.12 ± 59.835), there was 
no difference (Table 3).
Correlations of IL-6 and TNF-α concentrations were analyzed according to clini-
cal staging with parasitic index according to stage I, IL-6 (rs = 0.400, p = 0.5046) 
and TNF-α (rs = 0.700, p = 0.1881); stage II, IL-6 (rs = 0.7000, p = 0.1881) and 
TNF-α (rs = −0.1590, p = 0.6828); and stage III, IL-6 (rs = −0.3571, p = 0.4316) 
and TNF-α (rs = −0.4643, p = 0.2939). There was no correlation between the other 
parameters evaluated.
The correlation between the parasitic index of dogs with CVL in the presence 
of cytokine IL-4 and TNF-α in the blood of dogs infected with CVL presented the 
IL-4 (rs = 0.0240, p = 0.9176) and TNF-α (rs = 0.0825, p = 0.7221). No additional 
significant correlations were found. Antibody levels were positively correlated with 
IL-4 expression (rs = 0.5997, p = 0.0040) (Table 4).
Cytokines/parasitemia I II III p-Value
IL-2 6.62 ± 1.18 12.01 ± 7.99 15.09 ± 6.34 0.152
IL-4 10.50 ± 2.05 11.38 ± 3.81 9.90 ± 2.73 0.9044
IL-6 2.14 ± 0.57 2.72 ± 0.66 3.12 ± 0.50 0.0350
IL-10 2.47 ± 0.97 2.85 ± 0.96 2.39 ± 0.84 0.8973
IL-17 2.22 ± 0.22 12.38 ± 9.63 13.27 ± 7.51 0.4345
TNF-α 4.52 ± 2.12 4.65 ± 2.31 6.14 ± 1.43 0.0462
IFN 3.07 ± 0.99 28.19 ± 23.21 2.58 ± 0.28 0.4648
Parasite copy number (×107)/ml 4.96 ± 1.00 4.63 ± 1.37 4.55 ± 1.49 0.9467
The results were expressed in mean and standard error.
Table 1. 
Cytokine concentrations and parasite copy number (×107)/ml in dogs with visceral leishmaniasis in different 
clinical staging.
Cytokines Control CVL p-Value
IL-2 9.18 ± 6.14 11.75 ± 6.89 0.3199
IL-4 7.43 ± 2.50 12.56 ± 5.37 0.0469
IL-6 2.87 ± 0.95 2.71 ± 0.67 0.3326
IL-10 2.98 ± 1.39 2.62 ± 0.87 0.2807
IL-17 11.12 ± 12.12 11.63 ± 9.66 0.4570
TNF-α 2.80 ± 0.52 5.12 ± 2.33 0.0009
IFN 13.26 ± 16.88 16.15 ± 19.01 0.3589
The results were expressed in mean and standard error.
Table 2. 
Cytokine concentrations in dogs noninfected and dogs with canine visceral leishmaniasis.
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In this study, as shown in Table 5, the correlation of the evolution of clinical 
signs between the stages presented below was analyzed. There was a significant 
positive correlation of IL-6 cytokine levels between stage I and stage III.
4. Discussion
In this study the most dogs in the control group and CVL were mixed breed. 
The clinical symptoms of seropositive dogs (CVL) included lymphadenopathy, skin 
ulcers, onychogryphosis, ear ulceration, scaling, weight loss, and others. Dogs were 
classified into three clinical stages: stage I, mild disease; stage II, moderate disease; 
and stage III, severe disease. There was no statistical difference in the distribution 
between clinical stages and parasitic index. IL-6 and TNF-α concentrations increased 
in serum from infected dogs with a statistically significant difference between the 
clinical stages of CVL. Between the dogs with CVL and the control group, there was 
a statistical difference in the serum concentrations of cytokines IL-4 and TNF-α. IgG 
levels were elevated in the CVL group when compared to IgM levels. Antibody levels 
were positively correlated with IL-4 expression (rs = 0.5997; p = 0.0040). There was 
a significant positive correlation of IL-6 cytokine levels between stage I and stage III.
The clinical signs of CVL are important for the diagnosis. In the present study, 
the most prevalent clinical signs were lymphadenopathy, skin ulcers, onychogry-
phosis, ear ulceration, and scaling. However, prevalence is highly variable across 
Group Control CVL p-Value
IgG 636.94 ± 255.52 2288.04 ± 610.08 <0.0001
IgM 241.12 ± 51.81 282.42 ± 33.99 0.0773
The results were expressed in mean and standard error.
Table 3. 
Immunoglobulin concentrations (IgG and IgM) in serum from dogs with canine visceral leishmaniasis.
IgG
Parameters rs p-Value
IL-4 0.5997 0.0040
TNF-α 0.4164 0.0603
Parasitic index −0.2243 0.3282
rs, correlation coefficient of Spearman.
Table 4. 
Correlation between IgG concentrations with IL-4 and TNF-α and parasitic index of dogs infected with CVL.
Stage I and II I and III II and III
rs p rs p rs p
IL-6 0.6031 0.0855 0.8469 0.0162 0.5630 0.1144
TNF-α 0.0350 0.9288 0.3784 0.4026 0.0168 0.9658
rs, correlation coefficient of Spearman.
Table 5. 
Correlation of IL-6 and TNF-α cytokine levels of dogs with canine visceral leishmaniasis by clinical staging of 
serum from dogs of the CVL group.
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studies, but generally these clinical signs are the most commonly reported in the 
literature. These results corroborate the findings of several authors [25, 26].
Regarding gender, there was a greater predominance of males in infected dogs 
and females in dogs in the control group. Regarding age, it did not present large 
variations. This fact seems to be associated with the higher risk of male exposure. 
However, the study shows no statistically significant differences for age and gender 
between healthy and sick dogs [27].
Bone marrow samples were taken from 21 dogs serologically positive for L. 
infantum. According to the clinical signs, dogs were classified as stages I, II, and 
III. Real-time PCR detected no parasite copies (×1010)/μl L. infantum DNA in all 
animals of the CVL group, distributed as follows: stage I mean (4.964), stage II 
average (4.63), and stage III (4.55). No statistically significant difference was found 
in the average amount of DNA copy number between the different clinical stages 
(p = 0.9467). In bone marrow samples from dogs that are cytologically positive, a 
high parasitic index is detected [21].
Previous studies report that quantitative PCR on bone marrow samples from 
positive dogs in conventional tests contained a higher number of Leishmania kDNA 
copies than peripheral blood, although no significant differences were detected 
between symptomatic and asymptomatic dogs in terms of parasite load [28]. This 
literary quote converges with the findings of this study.
PCR can be used for detection of Leishmania in naturally infected dog samples, 
and PCR-RFLP (restriction fragment length polymorphism) is sensitive for iden-
tification of Leishmania species [28]. In addition, qPCR is effective in quantifying 
Leishmania DNA loading in clinical samples [29]. The blood sample from dogs 
infected by L. infantum was found by real-time PCR to have a sensitivity of 100% 
and specificity of 96.4% [30].
Most cytokines remain partially conserved between species; in this sense, the 
amino acid sequence of humans and canine cytokines shows 49–96% homology, 
suggesting a high probability of cross-reactivity between monoclonal antibodies; 
thus antibodies against human cytokines may be recommended as immunological 
biomarkers under pathological conditions by flow cytometry in human [31] and 
dogs [32] as used in this study.
In the present work, the serum concentration of cytokines (IL-2, IL-4, IL-6, 
IL-10, TNF-α, IFN-γ, and IL-17) was compared between the control groups and the 
group with CVL. In addition, cytokine levels were compared within the CVL group 
with clinical staging I, II, and III. When comparing the groups, IL-4 and TNF-α 
were higher in infected dogs than in the control group, showing significant differ-
ence between IL-4 (p = 0.0469) and TNF-α (p = 0.0009) groups. In the group with 
CVL there were differences between stages I and III with significant differences 
only for cytokines IL-6 (p = 0.0350) and TNF-α (p = 0.0462).
Elevated levels of IL-6 were found in serum from dogs with active leishmaniasis 
compared to healthy dogs [33]. These results corroborate the findings of this study. 
However, other authors reported that IL-6 production did not vary significantly 
between the groups studied [34]. On the other hand were described in the literature 
that elevated levels of IL-6 in dogs without clinical signs or symptoms in CVL 
dogs [35], and also highlights that, among other factors, it may indicate a balance 
between the parasite elimination effort and the active disease. Increased IL-6 levels 
suggest a restricted ability to control infection [36]. Even in the absence of clinical 
signs or symptoms, the animals showed granulomas on histopathological evalua-
tion, suggesting chronicity and therefore a longtime course of infection [35]. Innate 
immune effector cells primarily neutrophils, monocytes, and macrophages produce 
and respond to IL-6, which may result in amplification of inflammation and a 
change from an acute inflammatory state to a chronic state [37].
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IL-6 expression increases in dogs with active visceral leishmaniasis and may be 
a useful marker for active disease [33, 35]. Increased IL-6 production is not directly 
related to anti-Leishmania antibody titers, suggesting that other cytokines may be 
involved with hypergammaglobulinemia [33].
As shown in this work, it was observed that there was correlation of IL-6 
expression between stages I and III of bone marrow aspirate of dogs infected with 
CVL. IL-6 production in dogs with active leishmaniasis appears to be associated 
with severe disease [33]. This statement converges with the findings in this study, as 
the dogs used in the control group were mostly stage II and III. IL-6 is essential for 
terminal B-cell differentiation and immunoglobulin production [38].
TNF-α concentration was higher in infected dogs than in the control group, 
as detected by de Lima et al. [33]. CVL susceptibility is closely associated with 
downregulation of key cytokines such as IFN-γ, TNF-α, and IL-17A, thus impairing 
iNOS activation and NO production and favoring parasite replication and disease 
development [39].
The increased activity of TNF-α in the liver of infected dogs compared to 
healthy canines has been reported [37, 40]. Higher TNF-α levels in infected dogs 
indicate that the presence of L. infantum induces an immune response with relevant 
TNF-α expression when the protozoan is present [40].
Studies suggest that decreased survival of L. infantum in canine macrophages 
is associated with increased TNF-α and IFN-γ production and decreased IL-10 
production [41].
In dogs naturally infected with L. infantum, increased hepatic TNF-α may be 
associated with increased parasite load on this organ [42]. The cytokines IL-2, IL-4, 
IL-10, IFN-γ, TNF-α, and IL-12 may be used as markers in epidemiological studies 
conducted in endemic areas to distinguish between different clinical forms of VL 
[15]. However, Lima et al. [33] indicate that TNF-α is not considered a good marker 
of active disease in dogs with VL.
A study has reported a significant relationship between bone marrow IL-4 
detection in naturally infected dogs with and without clinical signs and disease 
severity, suggesting that IL-4 production is associated with pathology [43]. 
Increased expression of IL-4 cytokine is associated with both severe clinical signs 
and a high parasitic index on skin lesions [44]. In bone marrow aspirates, IL-4 was 
elevated in naturally infected dogs with more severe symptoms [43].
The study points to evidence that IL-4 cytokine polymorphism may contribute 
to innate immunity to L. infantum infection [45].
Antibody levels were positively correlated with IL-4 expression (rs = 0.5997; 
p = 0.0040). IgG is also linked to chronic infection in patients with VL, where high 
levels of IgG are predictive of the disease. This finding is in line with the study by 
Lima et al. [33] suggesting that other cytokines, such as IL-10 or IL-4, may be asso-
ciated with hypergammaglobulinemia observed in dogs with CVL. Previous studies 
have detected increased serum IgG levels in symptomatic dogs compared with 
healthy dogs and are related to pathophysiological disorders and active disease [33].
Response to natural infection of L. infantum is linked to the presence of IgG [43] 
and Leishmania-specific IgM antibodies that can be detected in infected dogs [46]. 
Some studies have reported that increased total protein is frequent in dogs infected 
with visceral leishmaniasis due to increased antibody production [47, 48].
5. Conclusion
These results may contribute to a better understanding of the immune response 
in dogs infected with L. infantum. Antibody levels were positively correlated with 
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IL-4 expression. There was a significant positive correlation of IL-6 cytokine 
levels with the evolution of stages I and III. However, this cytokine can be used as a 
marker to distinguish between different clinical stages.
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